Jim Cramer breaks down his latest thoughts on Biogen's controversial Alzheimer's drug.
Jim Cramer breaks down his latest thoughts on Biogen's controversial Alzheimer's drug.
In Thursday's episode of TheStreet Live, Jim Cramer discusses earnings from AT&T, Biogen, and Southwest, cryptocurrency and much..